首页> 外国专利> Combination of zd6474 an inhibitor of the vascularendothelial growth factor receptor with radiother apy in the treatment of cancer

Combination of zd6474 an inhibitor of the vascularendothelial growth factor receptor with radiother apy in the treatment of cancer

机译:血管内皮生长因子受体抑制剂zd6474与放射性核素联合治疗癌症

摘要

The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of ZD6474 in combination with ionising radiation; and to the use of ZD6474 in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is being treated with ionising radiation.
机译:本发明涉及在温血动物例如人中产生抗血管生成和/或血管通透性降低作用的方法,特别是用于治疗癌症,特别是涉及实体瘤的癌症的方法,包括与电离辐射一起施用ZD6474;以及ZD6474在制造药物中的用途,该药物用于在被电离辐射治疗的温血动物(如人)中产生抗血管生成和/或降低血管通透性的作用。

著录项

  • 公开/公告号IL166522D0

    专利类型

  • 公开/公告日2006-01-15

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号IL20050166522

  • 发明设计人

    申请日2005-01-26

  • 分类号7C07DA;

  • 国家 IL

  • 入库时间 2022-08-21 21:39:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号